Pharmaron Beijing Co., Ltd. (300759.SZ)
CNY 27.78
(-0.71%)
CNY 27.78
(-0.71%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 3.77 Billion CNY | -18.19% |
| 2022 | 4.61 Billion CNY | 165.26% |
| 2021 | 1.74 Billion CNY | 192.09% |
| 2020 | -1.89 Billion CNY | 44.74% |
| 2019 | -3.42 Billion CNY | -412.43% |
| 2018 | 1.09 Billion CNY | 10.0% |
| 2017 | 995.7 Million CNY | 544.34% |
| 2016 | 154.53 Million CNY | 24.48% |
| 2015 | 124.14 Million CNY | -16.25% |
| 2014 | 148.23 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 3.39 Billion CNY | -8.53% |
| 2024 Q3 | 2.97 Billion CNY | -0.18% |
| 2024 Q1 | 3.7 Billion CNY | -1.85% |
| 2023 Q3 | 4.13 Billion CNY | 15.09% |
| 2023 Q4 | 3.77 Billion CNY | -8.57% |
| 2023 FY | 3.77 Billion CNY | -18.19% |
| 2023 Q2 | 3.59 Billion CNY | -12.41% |
| 2023 Q1 | 4.09 Billion CNY | -11.25% |
| 2022 Q3 | 3.66 Billion CNY | 40.86% |
| 2022 FY | 4.61 Billion CNY | 165.26% |
| 2022 Q4 | 4.61 Billion CNY | 26.04% |
| 2022 Q1 | 2.48 Billion CNY | 42.65% |
| 2022 Q2 | 2.6 Billion CNY | 4.74% |
| 2021 Q3 | 855.17 Million CNY | 187.14% |
| 2021 Q1 | -827.93 Million CNY | 56.21% |
| 2021 Q4 | 1.74 Billion CNY | 103.62% |
| 2021 Q2 | -981.39 Million CNY | -18.53% |
| 2021 FY | 1.74 Billion CNY | 192.09% |
| 2020 FY | -1.89 Billion CNY | 44.74% |
| 2020 Q1 | -3.26 Billion CNY | 4.71% |
| 2020 Q2 | -2.66 Billion CNY | 18.23% |
| 2020 Q3 | -2.4 Billion CNY | 9.92% |
| 2020 Q4 | -1.89 Billion CNY | 21.28% |
| 2019 Q4 | -3.42 Billion CNY | -365.87% |
| 2019 FY | -3.42 Billion CNY | -412.43% |
| 2019 Q3 | 1.28 Billion CNY | 10.86% |
| 2019 Q2 | 1.16 Billion CNY | 61.39% |
| 2019 Q1 | 719.33 Million CNY | -34.32% |
| 2018 Q1 | 305.49 Million CNY | -69.32% |
| 2018 FY | 1.09 Billion CNY | 10.0% |
| 2018 Q2 | 1.25 Billion CNY | 312.07% |
| 2018 Q3 | 1.16 Billion CNY | -7.3% |
| 2018 Q4 | 1.09 Billion CNY | -6.15% |
| 2017 Q4 | 995.7 Million CNY | 0.0% |
| 2017 FY | 995.7 Million CNY | 544.34% |
| 2016 FY | 154.53 Million CNY | 24.48% |
| 2015 FY | 124.14 Million CNY | -16.25% |
| 2014 FY | 148.23 Million CNY | 0.0% |